|
1.
|
Norris P, Poston RN, Thomas DS, Thornhill
M, Hawk J and Haskard DO: The expression of ELAM-1, ICAM-1 and
VCAM-1 in experimental cutaneous inflammation: a comparison of UVb
erythema and delayed hypersensitivity. J Invest Dermatol.
96:763–970. 1991.PubMed/NCBI
|
|
2.
|
Yoo NC, Chung HC, Chung HC, et al:
Synchronous elevation of soluble intracellular adhesion molecule-1
(ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) correlates
with gastric cancer progression. Yonsei Med J. 39:27–36. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Shin J, Kim J, Ryu B, Chi SG and Park H:
Caveolin-1 associated with VCAM-1 dependent adhesion of gastric
cancer cells to endothelial cells. Cell Physiol Biochem.
17:211–220. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Higashiyama A, Watanabe H, Okumura K and
Yagita H: Involvement of tumor necrosis factor alpha and very late
activation antigen 4/vascular cell adhesion molecule 1 interaction
in surgical-stress enhanced experimental metastasis. Cancer Immunol
Immunother. 42:231–236. 1996. View Article : Google Scholar
|
|
5.
|
Ding YB, Chen GY, Xia JG, Zang XW, Yang HY
and Yang L: Association of VCAM-1 overexpression with oncogenesis,
tumor angiogenesis and metastasis of gastric carcinoma. World J
Gastroenterol. 9:1409–1414. 2003.PubMed/NCBI
|
|
6.
|
Velikova G, Banks RE, Gearing A, et al:
Circulating soluble adhesion molecules E-cadherin, E-selectin,
intracellular adhesion molecule-1 (ICAM-1) and vascular cell
adhesion molecule-1 (VCAM-1) in patients with gastric cancer. Br J
Cancer. 76:1398–1404. 1997. View Article : Google Scholar
|
|
7.
|
Gulubova MV: Expression of cell adhesion
molecules, their ligands and tumor necrosis factor alpha in the
liver of patients with metastatic gastrointestinal carcinomas.
Histochem J. 34:672002. View Article : Google Scholar
|
|
8.
|
Alexiou D, Karayiannakis AJ, Syrigos KN,
et al: Clinical significance of serum levels of E-selectin,
intracellular adhesion molecule-1 and vascular cell adhesion
molecule-1 in gastric cancer patients. Am J Gastroenterol.
98:478–485. 2003. View Article : Google Scholar
|
|
9.
|
Kobayashi H, Boelte KC and Lin PC:
Endothelial cell adhesion molecules and cancer progression. Curr
Med Chem. 14:377–386. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Wu TC: The role of vascular cell adhesion
molecule-1 in tumor immune evasion. Cancer Res. 67:6003–6006. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Gearing AJ, Hemingway I, Pigott R, Hughes
J, Rees AJ and Cashman SJ: Soluble forms of vascular adhesion
molecules, E-selectin, ICAM-1 and VCAM-1: pathological
significance. Ann NY Acad Sci. 667:324–331. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Alexiou D, Karayiannakis AJ, Syrigos KN,
Zbar A, Kremmyda A, Bramis I and Tsigris C: Serum levels of
E-selectin, ICAM-1 and VCAM-1 in colorectal cancer patients:
correlations with clinicopathological features, patient survival
and tumor surgery. Eur J Cancer. 37:2392–2397. 2001. View Article : Google Scholar
|
|
13.
|
O’Hanlon DM, Fitzsimons H, Lynch J, Tormey
S, Malone C and Given HF: Soluble adhesion molecules (E-selectin,
ICAM-1 and VCAM-1) in breast carcinoma. Eur J Cancer. 38:2252–2257.
2002.
|
|
14.
|
De Cicco C, Ravasi L, Zorzino L, et al:
Circulating levels of VCAM and MMP-2 may help identify patients
with more aggressive prostate cancer. Curr Cancer Drug Targets.
8:199–206. 2008.PubMed/NCBI
|
|
15.
|
Coskun U, Sancak B, Sen I, Bukan N, Tufan
MA, Gülbahar O and Sozen S: Serum P-selectin, soluble vascular cell
adhesion molecule-I (s-VCAM-I) and soluble intercellular adhesion
molecule-I (s-ICAM-I) levels in bladder carcinoma patients with
different stages. Int Immunopharmacol. 6:672–677. 2006. View Article : Google Scholar
|
|
16.
|
Christiansen I, Sundstrom C and Totterman
TH: Elevated serum levels of soluble vascular cell adhesion
molecule-1 (sVCAM-1) closely reflect tumour burden in chronic
B-lymphocytic leukemia. Br J Haematol. 103:1129–1137. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Shimizu Y, Newman W, Gopal TV, et al: Four
molecular pathways of T cell adhesion to endothelial cells: roles
of LFA-1, VCAM-1 and ELAM-1 and changes in pathway hierarchy under
different activation conditions. J Cell Biol. 113:1203–1212. 1991.
View Article : Google Scholar
|
|
18.
|
Makarem R, Newham P, Askari JA, et al:
Competitive binding of vascular cell adhesion molecule-1 and the
HepII/IIICS domain of fibronectin to the integrin alpha 4 beta 1. J
Biol Chem. 269:4005–4011. 1994.PubMed/NCBI
|
|
19.
|
Albelda SM: Role of integrins and other
cell adhesion molecules in tumor progression and metastasis. Lab
Invest. 68:4–17. 1993.PubMed/NCBI
|
|
20.
|
Ponta H, Sleeman J and Herrlich P: Tumor
metastasis formation: cell-surface proteins confer
metastasis-promoting or -suppressing properties. Biochem Biophys
Acta. 1198:1–10. 1994.PubMed/NCBI
|
|
21.
|
Ohene-Abuakwa Y and Pignatelli M: Adhesion
molecules as diagnostic tools in tumor pathology. Int J Surg
Pathol. 8:191–200. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Maurer CA, Friess H, Kretschmann B, et al:
Overexpression of ICAM-1, VCAM-1 and ELAM-1 might influence tumor
progression in colorectal cancer. Int J Cancer. 79:76–81. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Lloyd AR, Oppenheim JJ, Kelvin DJ and Taub
DD: Chemokines regulate T cell adherence to recombinant adhesion
molecules and extracellular matrix proteins. J Immunol.
156:932–938. 1996.PubMed/NCBI
|
|
24.
|
Kitani A, Nakashima N, Matsuda T, Xu B, Yu
S, Nakamura T and Matsuyama T: T cells bound by vascular cell
adhesion molecule-1/CD106 in synovial fluid in rheumatoid
arthritis: inhibitory role of soluble vascular cell adhesion
molecule-1 in T cell activation. J Immunol. 156:2300–2308.
1996.PubMed/NCBI
|
|
25.
|
Masumoto A and Hemler ME: Multiple
activation states of VLA-4. Mechanistic differences between
adhesion to CS1/fibronectin and to vascular cell adhesion
molecule-1. J Biol Chem. 268:228–234. 1993.PubMed/NCBI
|
|
26.
|
Garton KJ, Gough PJ, Philalay J, et al:
Stimulated shedding of vascular cell adhesion molecule 1 (VCAM-1)
is mediated by tumor necrosis factor-alpha-converting enzyme (ADAM
17). J Biol Chem. 278:37459–37464. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Singh RJ, Mason JC, Lidington EA, et al:
Cytokine stimulated vascular cell adhesion molecule-1 (VCAM-1)
ectodomain release is regulated by TIMP-3. Cardiovasc Res.
67:39–49. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Blanchot-Jossic F, Jarry A, Masson D, et
al: Up-regulated expression of ADAM17 in human colon carcinoma:
co-expression with EGFR in neoplastic and endothelial cells. J
Pathol. 207:156–163. 2005. View Article : Google Scholar : PubMed/NCBI
|
